A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy

Emanuela E Mihai, Marius N Popescu, Alina N Iliescu, Mihai Berteanu, Emanuela E Mihai, Marius N Popescu, Alina N Iliescu, Mihai Berteanu

Abstract

Introduction: The complexity of spasticity requires a continuous effort in terms of more adapted treatments for patients, and accurate management. Through this systematic review, we aimed to evaluate and compare the effectiveness of extracorporeal shock wave therapy (ESWT) with botulinum toxin type A (BoNT-A) on reducing spasticity both in children and adults.

Evidence acquisition: An electronic search of PubMed/Medline, Scopus, Ovid Medline(R), and search engine of Google Scholar was performed. Publications ranging from January 2010 to January 2021, published in the English language and available as full-texts were eligible for inclusion and they were searched without any country restriction. The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Guidelines.

Evidence synthesis: A total of five studies were included in the present systematic review. Screening of the references, data extraction, and risk of bias assessment were performed by two independent authors. The methodological quality and risk of bias were conducted using the Physiotherapy Evidence Database (PEDro) Scale. The primary outcome was spasticity grade assessed by the Modified Ashworth Scale (MAS) and/or Modified Tardieu Scale (MTS). Additional outcomes were active range of motion (AROM), passive range of motion (PROM), upper extremity Fugl-Meyer Assessment (UE-FMA), pain intensity assessed through Visual Analogue Scale (VAS), spasm frequency scale (SFS), sonographic parameters, between-group comparison, and treatment response rate.

Conclusions: A beneficial effect on spasticity was found for both treatments: evidence showed that ESWT and BoNT-A can ameliorate spasticity considering parameters such as MAS, MTS, AROM, PROM, UE-FMA, VAS and SFS in post-stroke, multiple sclerosis, and cerebral palsy patients. Further research is required to strengthen the evidence, and more suitable study protocols are highly needed.

Conflict of interest statement

Conflicts of interest.—The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Figures

Figure 1
Figure 1
—Flow diagram for selection and identification of studies included in the systematic review according to The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines.

References

    1. Martínez IM, Sempere-Rubio N, Navarro O, Faubel R. Effectiveness of Shock Wave Therapy as a Treatment for Spasticity: A Systematic Review. Brain Sci 2020;11:15. 10.3390/brainsci11010015
    1. Mills PB, Finlayson H, Sudol M, O’Connor R. Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity. Clin Rehabil 2016;30:537–48. 10.1177/0269215515593783
    1. Feldmann RG, Young RR, Koella WP. Spasticity, disordered motor control. Miami, FL: Symposia Specialists; 1980. p.485–95.
    1. Kinnear BZ, Lannin NA, Cusick A, Harvey LA, Rawicki B. Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a systematic review. Phys Ther 2014;94:1569–81. 10.2522/ptj.20130408
    1. Opheim A, Danielsson A, Alt Murphy M, Persson HC, Sunnerhagen KS. Upper-limb spasticity during the first year after stroke: stroke arm longitudinal study at the University of Gothenburg. Am J Phys Med Rehabil 2014;93:884–96. 10.1097/PHM.0000000000000157
    1. Brainin M, Norrving B, Sunnerhagen KS, Goldstein LB, Cramer SC, Donnan GA, et al. International PSS Disability Study Group . Poststroke chronic disease management: towards improved identification and interventions for poststroke spasticity-related complications. Int J Stroke 2011;6:42–6. 10.1111/j.1747-4949.2010.00539.x
    1. Gillard PJ, Sucharew H, Kleindorfer D, Belagaje S, Varon S, Alwell K, et al. The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study. Health Qual Life Outcomes 2015;13:159. 10.1186/s12955-015-0340-3
    1. Khan F, Amatya B, Bensmail D, Yelnik A. Non-pharmacological interventions for spasticity in adults: an overview of systematic reviews. Ann Phys Rehabil Med 2019;62:265–73.
    1. Jia G, Ma J, Wang S, Wu D, Tan B, Yin Y, et al. Long-term Effects of Extracorporeal Shock Wave Therapy on Post-stroke Spasticity: A Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis 2020;29:104591.
    1. Zorowitz RD, Gillard PJ, Brainin M. Poststroke spasticity: sequelae and burden on stroke survivors and caregivers. Neurology 2013;80(Suppl 2):S45–52. 10.1212/WNL.0b013e3182764c86
    1. Martin A, Abogunrin S, Kurth H, Dinet J. Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review. Neuropsychiatr Dis Treat 2014;10:111–22.
    1. Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, et al. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Brain 2006;129:224–34.
    1. Vidal X, Martí-Fàbregas J, Canet O, Roqué M, Morral A, Tur M, et al. Efficacy of radial extracorporeal shock wave therapy compared with botulinum toxin type A injection in treatment of lower extremity spasticity in subjects with cerebral palsy: A randomized, controlled, cross-over study. J Rehabil Med 2020;52:jrm00076. 10.2340/16501977-2703
    1. Krigger KW. Cerebral palsy: an overview. Am Fam Physician 2006;73:91–100.
    1. Dymarek R, Taradaj J, Rosińczuk J. The Effect of Radial Extracorporeal Shock Wave Stimulation on Upper Limb Spasticity in Chronic Stroke Patients: A Single-Blind, Randomized, Placebo-Controlled Study. Ultrasound Med Biol 2016;42:1862–75. 10.1016/j.ultrasmedbio.2016.03.006
    1. Gonkova MI, Ilieva EM, Ferriero G, Chavdarov I. Effect of radial shock wave therapy on muscle spasticity in children with cerebral palsy. Int J Rehabil Res 2013;36:284–90. 10.1097/MRR.0b013e328360e51d
    1. Radinmehr H, Nakhostin Ansari N, Naghdi S, Olyaei G, Tabatabaei A. Effects of one session radial extracorporeal shockwave therapy on post-stroke plantarflexor spasticity: a single-blind clinical trial. Disabil Rehabil 2017;39:483–90. 10.3109/09638288.2016.1148785
    1. Moon SW, Kim JH, Jung MJ, Son S, Lee JH, Shin H, et al. The effect of extracorporeal shock wave therapy on lower limb spasticity in subacute stroke patients. Ann Rehabil Med 2013;37:461–70. 10.5535/arm.2013.37.4.461
    1. Wu YT, Chang CN, Chen YM, Hu GC. Comparison of the effect of focused and radial extracorporeal shock waves on spastic equinus in patients with stroke: a randomized controlled trial. Eur J Phys Rehabil Med 2018;54:518–25. 10.23736/S1973-9087.17.04801-8
    1. Thibaut A, Chatelle C, Ziegler E, Bruno MA, Laureys S, Gosseries O. Spasticity after stroke: physiology, assessment and treatment. Brain Inj 2013;27:1093–105. 10.3109/02699052.2013.804202
    1. Salazar AP, Pinto C, Ruschel Mossi JV, Figueiro B, Lukrafka JL, Pagnussat AS. Effectiveness of static stretching positioning on post-stroke upper-limb spasticity and mobility: systematic review with meta-analysis. Ann Phys Rehabil Med 2019;62:274–82. 10.1016/j.rehab.2018.11.004
    1. Costantino C, Galuppo L, Romiti D. Short-term effect of local muscle vibration treatment versus sham therapy on upper limb in chronic post-stroke patients: a randomized controlled trial. Eur J Phys Rehabil Med 2017;53:32–40. 10.23736/S1973-9087.16.04211-8
    1. Kwong PW, Ng GY, Chung RC, Ng SS. Transcutaneous electrical nerve stimulation improves walking capacity and reduces spasticity in stroke survivors: a systematic review and meta-analysis. Clin Rehabil 2018;32:1203–19. 10.1177/0269215517745349
    1. McIntyre A, Lee T, Janzen S, Mays R, Mehta S, Teasell R. Systematic review of the effectiveness of pharmacological interventions in the treatment of spasticity of the hemiparetic lower extremity more than six months post stroke. Top Stroke Rehabil 2012;19:479–90. 10.1310/tsr1906-479
    1. Bakheit AM. The pharmacological management of post-stroke muscle spasticity. Drugs Aging 2012;29:941–7. 10.1007/s40266-012-0034-z
    1. Montané E, Vallano A, Laporte JR. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology 2004;63:1357–63. 10.1212/01.WNL.0000141863.52691.44
    1. Bethoux F. Spasticity Management After Stroke. Phys Med Rehabil Clin N Am 2015;26:625–39. 10.1016/j.pmr.2015.07.003
    1. Dromerick AW. Clinical features of spasticity and principles of treatment. In: Gelber DA, Jeffery DR, editors. Clinical evaluation and management of spasticity. New York, NY: Humana Press; 2002.
    1. Opara J, Taradaj J, Walewicz K, Rosińczuk J, Dymarek R. The Current State of Knowledge on the Clinical and Methodological Aspects of Extracorporeal Shock Waves Therapy in the Management of Post-Stroke Spasticity-Overview of 20 Years of Experiences. J Clin Med 2021;10:261. 10.3390/jcm10020261
    1. Monaghan K, Horgan F, Blake C, Cornall C, Hickey PP, Lyons BE, et al. Physical Treatment Interventions for Managing Spasticity after Stroke. Cochrane Library; 2017 [Internet]. Available from: [cited 2022, Apr 11].
    1. Mihai EE, Dumitru L, Mihai IV, Berteanu M. Long-Term Efficacy of Extracorporeal Shock Wave Therapy on Lower Limb Post-Stroke Spasticity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med 2020;10:86. 10.3390/jcm10010086
    1. Picelli A, Santamato A, Chemello E, Cinone N, Cisari C, Gandolfi M, et al. Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature. Ann Phys Rehabil Med 2019;62:291–6. 10.1016/j.rehab.2018.08.004
    1. Zschorlich VR, Hillebrecht M, Tanjour T, Qi F, Behrendt F, Kirschstein T, et al. Repetitive Peripheral Magnetic Nerve Stimulation (rPMS) as Adjuvant Therapy Reduces Skeletal Muscle Reflex Activity. Front Neurol 2019;10:930. 10.3389/fneur.2019.00930
    1. Dressler D, Altavista MC, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, et al. Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity. J Neural Transm (Vienna) 2021;128:321–35. 10.1007/s00702-021-02312-4
    1. Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2016;86:1818–26. 10.1212/WNL.0000000000002560
    1. Shrivastava SK, Kailash. Shock wave treatment in medicine. J Biosci 2005;30:269–75. 10.1007/BF02703708
    1. Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet 1980;2:1265–8. 10.1016/S0140-6736(80)92335-1
    1. Dolibog P, Dolibog PT, Franek A, Brzezińska-Wcisło L, Wróbel B, Arasiewicz H, et al. Comparison of ultrasound therapy and radial shock wave therapy in the treatment of venous leg ulcers - clinical, pilot study. Postepy Dermatol Alergol 2018;35:454–61. 10.5114/ada.2018.79191
    1. Guo J, Qian S, Wang Y, Xu A. Clinical study of combined mirror and extracorporeal shock wave therapy on upper limb spasticity in poststroke patients. Int J Rehabil Res 2019;42:31–5. 10.1097/MRR.0000000000000316
    1. Marinaro C, Costantino C, D’Esposito O, Barletta M, Indino A, De Scorpio G, et al. Synergic use of botulinum toxin injection and radial extracorporeal shockwave therapy in Multiple Sclerosis spasticity. Acta Biomed 2021;92:e2021076.
    1. Wang T, Du L, Shan L, Dong H, Feng J, Kiessling MC, et al. A Prospective Case-Control Study of Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Very Young Children With Cerebral Palsy. Medicine (Baltimore) 2016;95:e3649. 10.1097/MD.0000000000003649
    1. Xiang J, Wang W, Jiang W, Qian Q. Effects of extracorporeal shock wave therapy on spasticity in post-stroke patients: A systematic review and meta-analysis of randomized controlled trials. J Rehabil Med 2018;50:852–9. 10.2340/16501977-2385
    1. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336–41. 10.1016/j.ijsu.2010.02.007
    1. de Morton NA. The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Aust J Physiother 2009;55:129–33. 10.1016/S0004-9514(09)70043-1
    1. Santamato A, Notarnicola A, Panza F, Ranieri M, Micello MF, Manganotti P, et al. SBOTE study: extracorporeal shock wave therapy versus electrical stimulation after botulinum toxin type a injection for post-stroke spasticity-a prospective randomized trial. Ultrasound Med Biol 2013;39:283–91. 10.1016/j.ultrasmedbio.2012.09.019
    1. Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial. Arch Phys Med Rehabil 2018;99:2143–50. 10.1016/j.apmr.2018.05.035
    1. Picelli A, La Marchina E, Gajofatto F, Pontillo A, Vangelista A, Filippini R, et al. Sonographic and clinical effects of botulinum toxin Type A combined with extracorporeal shock wave therapy on spastic muscles of children with cerebral palsy. Dev Neurorehabil 2017;20:160–4. 10.3109/17518423.2015.1105320
    1. Barotsis N, Tsiganos P, Kokkalis Z, Panayiotakis G, Panagiotopoulos E. Reliability of muscle thickness measurements in ultrasonography. Int J Rehabil Res 2020;43:123–8. 10.1097/MRR.0000000000000390
    1. Popescu MN, Petca RC, Beiu C, Dumitrascu MC, Petca A, Mehedintu C, et al. Efficiency of Different Preparations of Botulinum Toxin Type A, Xeomin and Dysport, in the Management of Spastic Upper Limb After Stroke. Rev.Chim. 2019;70:3490–4. 10.37358/RC.19.10.7582
    1. Rekand T, Biering-Sörensen B, He J, Vilholm OJ, Christensen PB, Ulfarsson T, et al. Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity. BMJ Open 2019;9:e024340. 10.1136/bmjopen-2018-024340
    1. Marciniak C, McAllister P, Walker H, Brashear A, Edgley S, Deltombe T, et al. ; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial. PM R 2017;9:1181–90. 10.1016/j.pmrj.2017.06.007
    1. Mihai EE, Popescu MN, Beiu C, Gheorghe L, Berteanu M. Tele-Rehabilitation Strategies for a Patient With Post-stroke Spasticity: A Powerful Tool Amid the COVID-19 Pandemic. Cureus 2021;13:e19201. 10.7759/cureus.19201
    1. Manganotti P, Amelio E. Long-term effect of shock wave therapy on upper limb hypertonia in patients affected by stroke. Stroke 2005;36:1967–71. 10.1161/01.STR.0000177880.06663.5c
    1. Mariotto S, de Prati AC, Cavalieri E, Amelio E, Marlinghaus E, Suzuki H. Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Curr Med Chem 2009;16:2366–72. 10.2174/092986709788682119
    1. Matak I, Bölcskei K, Bach-Rojecky L, Helyes Z. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins (Basel) 2019;11:459. 10.3390/toxins11080459
    1. Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 2005;26:785–93. 10.1016/j.neuro.2005.01.017
    1. Stucki G, Bickenbach J, Gutenbrunner C, Melvin J. Rehabilitation: the health strategy of the 21st century. J Rehabil Med 2018;50:309–16. 10.2340/16501977-2200

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren